Hamilton, Lindsey R.
Schachter, Steven C.
Myers, Todd M.
Funding for this research was provided by:
Defense Threat Reduction Agency (To be supplied)
Article History
Received: 25 August 2016
Revised: 16 November 2016
Accepted: 21 November 2016
First Online: 30 November 2016
Compliance with Ethical Standards
:
: Dr. Schachter is inventor on a patent for the use of huperzine for treatment of epilepsy, which is licensed by Harvard Medical School to Biscayne Pharmaceuticals, Inc., in which he holds less than 5% equity and for which he serves as chair of the scientific advisory board. The remaining authors have no conflicts of interest.
: The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Army, Department of Defense, or the U.S. Government.
: All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.